From: The role of dyslipidemia and statins in venous thromboembolism
 |  |  |  |  |  | Prevalence |  |
---|---|---|---|---|---|---|---|
 |  |  |  |  |  | of lipid | Odds |
 |  | Mean age |  | % cases |  | risk factor | ratio |
 | No. cases/ | of cases | VTE | with situational |  | among | (95% CI) |
Study [reference] | controls | (years) | type | risk factors* | Serum lipid risk factor(s) | cases (%) | for VTE |
Goldhaber et al [7] | 280/112542 | 30–55 | PE | 55 | Self-reported elevated TC | 18 | 1.1 (0.7–1.5) |
Kawasaki et al [8] | 109/109 | 50 | Leg DVT | 34 | TC > 5.7 mmol/L and TG > 1.7 mmol/L | 23 | 5.1 (2.0–13.0) |
 |  |  |  |  | TC > 5.7 mmol/L and TG ≤ 1.7 mmol/L | 26 | 2.6 (1.2–5.3) |
Nowak-Gottl et al [10] | 186/186 | 5 | Any VTE | 60 | Lp(a) > 30 mg/dL | 42 | 7.2 (3.7–14.5) |
von Depka et al [11] | 685/266 | 34 | Any VTE | 21 | Lp(a) > 10 mg/dL | 40 | 1.6 (1.2–2.2) |
 |  |  |  |  | Lp(a) > 20 mg/dL | 25 | 2.2 (1.5–3.3) |
 |  |  |  |  | Lp(a) > 30 mg/dL | 20 | 3.2 (1.9–5.3) |